75A50125C00017
Definitive Contract
Overview
Government Description
DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
Awardee
Awarding / Funding Agency
Place of Performance
San Diego, CA 92121 United States
Pricing
Cost Plus Fixed Fee
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
414
Related Opportunity
None
Cidara Therapeutics was awarded
Definitive Contract 75A50125C00017 (75A501-25-C-00017)
worth up to $339,189,481
by the HHS Office of the Assistant Secretary for Preparedness and Response
in September 2025.
The contract
has a duration of 4 years 10 months and
was awarded
full & open
with
NAICS 541714 and
PSC AN14
via direct negotiation acquisition procedures with 1 bid received.
As of today, the Definitive Contract has a total reported backlog of $281,137,498.
Status
(Open)
Last Modified 9/30/25
Period of Performance
9/30/25
Start Date
9/29/27
Current End Date
7/3/30
Potential End Date
Obligations and Backlog
$58.1M
Total Obligated
$58.1M
Current Award
$339.2M
Potential Award
$0.0
Funded Backlog
$281.1M
Total Backlog
Award Hierarchy
Definitive Contract
75A50125C00017
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75A50125C00017
Competition
Number of Bidders
1
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
FKP3JZ9RUNY9
Awardee CAGE
7A5L2
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhsrmarion
Last Modified By
hhsrmarion
Approved By
hhsrmarion
Legislative
Legislative Mandates
None Applicable
Performance District
CA-51
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Representative
Sara Jacobs
Modified: 9/30/25